Publications by authors named "Simon Cheesman"

Claim this Profile
I
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
George Nesr, Raakhee Shah, Charalampia Kyriakou, Jonathan Sive, Rakesh Popat, Simon Cheesman

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set.
Monica Ziff, Gabrielle Lawson, Dunnya De-Silva, Simon Cheesman, Charalampia Kyriakou

Leuk Lymphoma· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
Louise Ainley, Selina J Chavda, Nicholas Counsell, Simon Cheesman, Fiona Newrick

Br J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of Biosimilar Rituximab: A Hospital Perspective.
Simon Cheesman

Hemasphere· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Oliver C Cohen, Maximillian H Brodermann, Iona J Blakeney, Shameem Mahmood, Sajitha Sachchithanantham, Simon Cheesman

Amyloid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
Selina J Chavda, Rachael Pocock, Simon Cheesman, Kyung-Min Lee, Emma Dowling

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis.
Oliver C Cohen, Faye Sharpley, Julian D Gillmore, Helen J Lachmann, Sajitha Sachchithanantham, Simon Cheesman

Br J Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham, Helen J Lachmann, Julian D Gillmore, Simon Cheesman

Br J Haematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy.
Lucy Neave, Daniel P Gale, Simon Cheesman, Raakhee Shah, Marie Scully

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune-mediated thrombotic thrombocytopenic purpura.
Matthew J Stubbs, Ryan Low, Siobhan McGuckin, Rosalind Newton, Mari Thomas, Simon Cheesman

Br J Haematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.
Yasmin Reyal, Rakesh Popat, Simon Cheesman, Ali Rismani, Shirley D'Sa

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.
Nicola Maciocia, Andrew Melville, Simon Cheesman, Faye Sharpley, Karthik Ramasamy

Br J Haematol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy.
Paul Maciocia, Mohsin Badat, Simon Cheesman, Shirley D'Sa, Rahul Joshi

Br J Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma.
Rakesh Popat, Iftekhar Khan, Jenny Dickson, Simon Cheesman, Dean Smith

Br J Haematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experience.
Jonathan Sive, Kirit M Ardeshna, Simon Cheesman, Franel le Grange, Stephen Morris

Leuk Lymphoma· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis